ANCOUVER, British Columbia — AbCellera Biologics today announced that it has filed a lawsuit in the United States District Court for the District of Delaware against Berkeley Lights, Inc. for patent infringement of U.S. Patent Nos. 10,107,812; 10,274,494; 10,466,241; 10,578,618; 10,697,962; 10,087,408; 10,421,936; and 10,704,018. By its complaint, AbCellera is seeking a declaration by the […]
BALTIMORE, MD – PathSensors Inc., a Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to include clinical applications for CANARY™ technology. This broader license allows PathSensors to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly sensitive assays will […]
London and Oxford, UK: Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a comprehensive portfolio of native and recombinant […]
Lincoln, NE: The SARS-CoV-2 coronavirus and subsequent COVID-19 pandemic places the subject of viruses and virology in the research spotlight for good reason. Scientists are seeking to understand the virus, characterize infectivity, and understand its mechanism of action in their quest to develop therapeutics and vaccines. Key to this process are quantifiable assays that provide robust data for all aspects […]
FARMINGDALE, N.Y. – New York-based biotechnology firm EpiGentek has released a series of SARS-CoV-2 research assays in combatting the ongoing COVID-19 pandemic. The two kits focus on studies of SARS-CoV-2 targeted furin or proprotein convertase (PC) cleavage activity. These first-of-its-kind tools can be used to rapidly detect SARS-CoV-2 targeted PC and facilitated proteases using biological […]
Bionano’s new Bionano Prep™ SP Tissue and Tumor Kit enables routine analysis of cancer biopsies and animal tissue expanding its addressable market to include solid tumors and model genomes commonly studied in pharmaceutical research and development SAN DIEGO — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has launched the new Bionano PrepTM SP […]
— Multiplexed Target Enrichment Panel Sequences the Entire Viral Genome for High Coverage of Target Regions, Better Accuracy and Mutation Tracking — CleanPlex® Technology Produces High Quality Sequence-Ready Libraries with Excellent Sensitivity in Just 5.5 Hours Using an Efficient Workflow and Reducing Sequencing Costs by 99% — Paragon Genomics Is Developing New Barcoding Method Enabling […]
Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S. SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the TruSight™ Software Suite. TruSight Software delivers ready-made infrastructure to realize […]
Recombinant engineered antibodies for COVID-19 diagnostics and therapeutic development Redcar, UK. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19. Under the partnership, the original nanobodies and newly […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a partnership with Takeda Pharmaceutical Company Limited (Takeda) for access to proprietary phage display libraries for the discovery, validation and optimization of antibodies in Takeda’s pipeline […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
